Published in Lancet on January 16, 1999
Acceptability of cancer chemoprevention trials: impact of the design. Int J Med Sci (2008) 0.78
Drop-outs in tamoxifen prevention trials. Lancet (1999) 0.78
Is tamoxifen effective in prevention of breast cancer? Lancet (1998) 2.23
Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol (2007) 11.04
Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med (1976) 9.68
Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet (2001) 7.92
Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med (1993) 7.67
Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med (1981) 7.53
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet (1997) 6.99
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Breast cancer (1) N Engl J Med (1992) 4.79
Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 4.76
Overview of the main outcomes in breast-cancer prevention trials. Lancet (2003) 4.31
Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst (1997) 4.23
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst (1999) 4.04
Sources of concern about the Patient Self-Determination Act. N Engl J Med (1991) 3.90
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet (1998) 3.83
Results of a breast-cancer-surgery trial compared with observational data from routine practice. Lancet (1996) 3.78
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med (1977) 3.45
Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 3.25
The specific-word frequency effect: implications for the representation of homophones in speech production. J Exp Psychol Learn Mem Cogn (2001) 2.74
ABC of colorectal cancer: Epidemiology. BMJ (2000) 2.71
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer (1982) 2.71
The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med (1995) 2.49
Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet (1999) 2.48
Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 2.47
Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet (1984) 2.47
Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol (2001) 2.42
Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology (1999) 2.41
Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer (1981) 2.40
Sexual factors and prostate cancer. BJU Int (2003) 2.38
The Elag-Koln automatic blood pressure recorder. A clinical appraisal. Br Heart J (1977) 2.34
The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. Cancer (1977) 2.33
Hemoconcentration: an early marker of severe and/or necrotizing pancreatitis? A critical appraisal. Am J Gastroenterol (2001) 2.28
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Res Treat (2001) 2.26
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst (1990) 2.25
Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol (1993) 2.23
Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol (2009) 2.20
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
The effect of environmental tobacco smoke in two urban communities in the west of Scotland. Eur J Respir Dis Suppl (1984) 2.15
Tamoxifen for breast cancer among hysterectomised women. Lancet (2002) 2.11
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer. Ann Oncol (2006) 2.10
Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology (2001) 2.10
Therapy for testicular cancer in Central and Eastern Europe. Lancet (1990) 2.08
The FtsJ/RrmJ heat shock protein of Escherichia coli is a 23 S ribosomal RNA methyltransferase. J Biol Chem (2000) 2.07
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst (1994) 2.06
Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol (1986) 2.05
Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol (2002) 2.03
[Prevalence and risk factors of hepatitis C virus infection in a hospitalized population in a gastroenterology unit. Role of endoscopic biopsies]. Gastroenterol Clin Biol (1995) 2.01
The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia (2002) 1.99
1st International consensus guidelines for advanced breast cancer (ABC 1). Breast (2012) 1.96
Will the sentinel lymph node (SLN) stand a second time--SLN biopsy in breast cancer patients with isolated local recurrence following breast conserving therapy and previous SLN procedure. Ann Oncol (2001) 1.94
Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J Natl Cancer Inst (1998) 1.91
Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis (1992) 1.90
Age-period-cohort models: a comparative study of available methodologies. J Clin Epidemiol (1999) 1.90
Tar concentrations in cigarettes and carcinogen content. Lancet (1998) 1.85
Locoregional recurrence risk after lipofilling in breast cancer patients. Ann Oncol (2011) 1.84
Western and eastern European trends in testicular cancer mortality. Lancet (2001) 1.80
A case-control study of diabetes mellitus and cancer risk. Br J Cancer (1994) 1.76
Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer (1978) 1.75
Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study. Cancer (1976) 1.75
Chronic pancreatitis: report from a multicenter Italian survey (PanCroInfAISP) on 893 patients. Dig Liver Dis (2008) 1.74
Oral cancer in Scotland: changing incidence and mortality. BMJ (1992) 1.74
Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res (2000) 1.72
Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol (2005) 1.72
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications. Ann Oncol (2007) 1.69
Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache (1993) 1.69
Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies? J Clin Pathol (1982) 1.69
Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology (1998) 1.68
Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst (2001) 1.68
Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer. Eur J Cancer (1998) 1.68
Labeling index as a prognostic marker in non-Hodgkin's lymphomas. J Natl Cancer Inst (1981) 1.68
Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst (1997) 1.68
Outcome of special types of luminal breast cancer. Ann Oncol (2011) 1.67
Trends of cancer mortality in Europe, 1955-1989: II, Respiratory tract, bone, connective and soft tissue sarcomas, and skin. Eur J Cancer (1992) 1.66
Variation within global cigarette brands in tar, nicotine, and certain nitrosamines: analytic study. Tob Control (2000) 1.65
Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer (1983) 1.65
Lipopolysaccharide, tumor necrosis factor, and interleukin-1 interact to cause hypotension. J Lab Clin Med (1992) 1.65
Cancer-testis antigen expression in triple-negative breast cancer. Ann Oncol (2010) 1.65
Pancreatitis and the risk of pancreatic cancer. Pancreas (1995) 1.64
Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA (2001) 1.64
An autoregulatory feedback loop directs the localized expression of the Drosophila CPEB protein Orb in the developing oocyte. Development (2001) 1.62
Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. J Natl Cancer Inst (1997) 1.60
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. Ann Oncol (2005) 1.60
Age-period-cohort analysis of chronic disease rates. I: Modelling approach. Stat Med (1998) 1.59